Hosts
Top Stories from CNBC- JPMorgan subsidiary to sell Saudi Investment Bank stake for $203m
- Polls open in Turkey's high-stakes elections
- US homeland security says 522 children have been reunited with families, 2,053 still in custody
- A top economy watcher says a spike in oil and copper prices is hiding what could be a slowdown
- Andy Cohen on the making of a 'Housewives' brand
Health Care
New diet-based approaches to diabetes prevention and treatment include fresh-food prescriptions and ketogenic diets rather than drugs alone. Spending on drugs reached $53 billion last year, with mixed results.
Say hello to the health savings account. It’s your next pot of retirement dollars. How to get the most out of your account.
They plan to open two locations inside Walgreens stores this fall in the Kansas City, Missouri, area with primary care services, pharmacies and other services like a Humana representative to answer seniors’ Medicare questions.
The CDC found more than half of people who committed suicide did not have a known diagnosed mental health condition when they died.
Athenahealth CEO Jonathan Bush will step down, and the company will search for a new leader and explore strategic alternatives, the company said Wednesday.
Drug prices fell more than 5 percent in the first quarter, a new analysis found. But what caused the decrease can actually increase costs for patients.
The legislation allows patients with life-threatening conditions to ask drugmakers for medicines that have cleared some testing but still haven’t been approved by the Food and Drug Administration.
U.S. equities opened little changed on Friday, as Wall Street looked to book a week of solid gains led by energy stocks.
Trump’s American Patients First would lower list prices for prescription drugs and limit regulations.
If you enroll in Medicare without weighing your options, you could end up with unexpected health costs. Here’s how to avoid them.
As allergy season kicks into full swing, Meg Tirrell takes a look at what companies stand to benefit.
Opioid prescriptions are on the decline in the U.S., according to a new report from the Iqvia Institute. But experts say the number is still too high.
Allergan will not bid for Shire, according to sources close to the company.
The senators join the growing chorus of people calling on the Food and Drug Administration to help stop Juul’s popularity among kids and teens.
Meg Tirrell takes a look at the advancements Merck is making in treating lung cancer.
